Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2018
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 10 Oct 2018 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 05 Jun 2017 Planned End Date changed from 15 Aug 2017 to 15 Sep 2017.